Optimizing Frontline Treatment Approaches in EGFRm Metastatic NSCLC - Episode 13
Panelists discuss how a 45-year-old anxious patient who refused chemotherapy was successfully treated with amivantamab plus lazertinib along with prophylactic management strategies for potential adverse effects.
Case Presentation 2 – Patient With Treatment Preferences
Main Discussion Topics:
Key Points for Physicians:
Notable Insights:
Patient education involved balancing data-driven information about efficacy with counseling about expected toxicities and management strategies.
Clinical Significance:
This case demonstrates how treatment selection can be successfully tailored to align with patient preferences while still providing optimal efficacy for high-risk disease features.